AnGes and BioLeaders link up for novel oral DNA vaccine against hypertension
This article was originally published in Scrip
Executive Summary
The Japanese venture AnGes MG has entered into a collaboration with South Korea's BioLeaders Corp for the research and development of a novel oral vaccine for the treatment of hypertension.